"
Follistatin, a Novel Biomarker for Malignant Gliomas"
written by Elvira Lekka, Nicolas Tsesmetzis, Katherine M. Ashton, Peter Abel, Charles Davies, Gregory Hall, Timothy Dawson, Robert W. Lea,
published by
Neuroscience and Medicine,
Vol.6 No.3, 2015
has been cited by the following article(s):
|
[1]
|
Secretomics identifies follistatin as a predictive biomarker for response to treatment with tyrosine kinase inhibitors in synovial sarcoma
Journal of Electrophoresis,
2017
DOI:10.2198/jelectroph.61.1
|
|
|
|